Vision Loss Drug Shows Promise for Diabetic Blindness
A drug currently used to slow vision loss also shows promise for treating blindness in diabetics, according to researchers at the Johns Hopkins Wilmer Eye Institute in a study published in the December issue of American Journal of Ophthalmology.
Subjects suffering from vision loss due to macular edema, one the complications of diabetes and a first stage of diabetic retinopathy, were treated with ranibuzumab for several months. All showed an improvement of at least two more lines on a standard eye chart.
“The results are impressive, although we will not know until we begin a larger clinical trial what the long-term benefits of the drug might be,” one researcher said.
(via All Headline News)
Related Stories
POSTED IN: Research
0 opinions for Vision Loss Drug Shows Promise for Diabetic Blindness
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: